WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant Campylobacter jejuni
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.04322-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Kentaro Koide und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bioresources, Hokkaido University International Institute for Zoonosis Control, Sapporo, Japan. Hauptthemen laut MEDLINE: Campylobacter jejuni, Microbial Sensitivity Tests, Anti-Bacterial Agents, DNA Gyrase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Japan Society for the Promotion of Science (JSPS).
Abstract (Originalsprache)
Quinolone-resistant Campylobacter jejuni have been increasing worldwide. Quinolones exert their antibacterial activity by inhibiting DNA gyrase, but most of the isolates acquire quinolone resistance via an amino acid substitution in the A subunit of DNA gyrase. WQ-3810 is a quinolone antibiotic that has been reported to have high potency even to DNA gyrase with amino acid substitutions in several bacterial species; however, there was no information on C. jejuni . Hence, this study aimed to evaluate the activity of WQ-3810 to inhibit wild-type/mutant DNA gyrases of C. jejuni and the bacterial growth for accessing the potency for the treatment of quinolone-resistant C. jejuni infection. The inhibitory activity of WQ-3810 was assessed and compared with ciprofloxacin and nalidixic acid by calculating the half maximal inhibitory concentration (IC 50 ) against wild-type/mutant DNA gyrases. Next, the minimum inhibitory concentration (MIC) of WQ-3810 and five other quinolones was determined for C. jejuni including quinolone-resistant strains with amino acid substitutions in GyrA. Furthermore, the interaction between WQ-3810 and wild-type/mutant DNA gyrase was speculated using docking simulations. The IC 50 of WQ-3810 against wild-type DNA gyrase was 1.03 µg/mL and not different from that of ciprofloxacin. However, those of WQ-3810 against mutant DNA gyrases were much lower than ciprofloxacin. The MICs of WQ-3810 ranged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Bioresources, Hokkaido University International Institute for Zoonosis Control, Sapporo, Japan.
- Department of Bacteriology II, National Institute of Infectious Diseases, Musashimurayama, Japan.
- School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Ireland.
- Faculty of Public Health, Thammasat University, Pathum Thani, Thailand.
- School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
- International Collaboration Unit, Hokkaido University, Sapporo, Japan.
ORCID-Profile: Kentaro Koide, Tadhg Ó Cróinín, Jeewan Thapa, Yasuhiko Suzuki
Förderung
- Japan Agency for Medical Research and Development (AMED)
- Japan Society for the Promotion of Science (JSPS)
Zitieren
APA
Koide, K., Kim, H., Whelan, M. V. X., Belotindos, L. P., Tanomsridachchai, W., Changkwanyeun, R., Usui, M., Ó Cróinín, T., Thapa, J., Nakajima, C., & Suzuki, Y. (2024). WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant Campylobacter jejuni. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04322-23
Vancouver
Koide K, Kim H, Whelan MVX, Belotindos LP, Tanomsridachchai W, Changkwanyeun R, et al. WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant Campylobacter jejuni. Microbiology Spectrum. 2024. doi:10.1128/spectrum.04322-23
BibTeX
@article{Koide2024,
author = {Koide, Kentaro and Kim, Hyun and Whelan, Matthew V X and Belotindos, Lawrence P and Tanomsridachchai, Wimonrat and Changkwanyeun, Ruchirada and Usui, Masaru and Ó Cróinín, Tadhg and Thapa, Jeewan and Nakajima, Chie and Suzuki, Yasuhiko},
title = {WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant Campylobacter jejuni},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.04322-23}
}
EUVIMED